Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$381K Sell
7,543
-243
-3% -$14.9K ﹤0.01% 1258
2026
Q1
$508K Buy
7,786
+2,430
+45% +$178K ﹤0.01% 1011
2025
Q4
$431K Sell
5,356
-3
-0.1% -$241 ﹤0.01% 1012
2025
Q3
$440K Sell
5,359
-14
-0.3% -$1.21K ﹤0.01% 1014
2025
Q2
$490K Buy
5,373
+34
+0.6% +$3.04K ﹤0.01% 959
2025
Q1
$489K Buy
5,339
+300
+6% +$26.2K ﹤0.01% 937
2024
Q4
$429K Buy
5,039
+675
+15% +$59.2K ﹤0.01% 1001
2024
Q3
$382K Buy
4,364
+29
+0.7% +$2.44K ﹤0.01% 1019
2024
Q2
$342K Buy
4,335
+17
+0.4% +$1.4K ﹤0.01% 1018
2024
Q1
$390K Sell
4,318
-170
-4% -$15.5K ﹤0.01% 1019
2023
Q4
$394K Buy
4,488
+19
+0.4% +$1.58K ﹤0.01% 1001
2023
Q3
$378K Buy
4,469
+348
+8% +$31.4K 0.01% 983
2023
Q2
$407K Hold
4,121
0.01% 968
2023
Q1
$396K Sell
4,121
-31
-0.7% -$2.87K 0.01% 975
2022
Q4
$377K Buy
+4,152
New +$353K 0.01% 983

Other funds holding DOX

Xponance's DOX Position: Q2 2026 in Review

Xponance reduced its Amdocs (DOX) stake by 3.1% in Q2 2026, selling an estimated $14.9K and leaving 7,543 shares worth $381K. The position accounts for ﹤0.01% of the portfolio, ranked #1258.

Xponance first reported a position in DOX in Q4 2022 and has held it in 15 quarters since. The position peaked at $508K in Q1 2026. 447 funds tracked by Wall St. Rank hold DOX as of Q2 2026.

  • Xponance held 7,543 shares of Amdocs worth $381K as of Q2 2026.
  • Xponance sold 243 Amdocs shares in Q2 2026, an estimated $14.9K.
  • Amdocs made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1258 holding.
  • Xponance first reported a position in Amdocs in Q4 2022 and has held it in 15 quarters since.
  • Xponance's Amdocs position peaked at $508K in Q1 2026.
  • 447 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.